On Invalid Date, Quest Diagnostics (NYSE: DGX) reported Q3 2022 earnings per share (EPS) of $2.20, up 46.47% year over year. Total Quest Diagnostics earnings for the quarter were $256.00 million. In the same quarter last year, Quest Diagnostics's earnings per share (EPS) was $4.11.
As of Q1 2023, Quest Diagnostics's earnings has grown -38.77% year over year. This is 41.31 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 2.54%. Quest Diagnostics's earnings in the past year totalled $1.24 billion.
What was DGX's revenue last quarter?
On Invalid Date, Quest Diagnostics (NYSE: DGX) reported Q3 2022 revenue of $2.49 billion up 10.38% year over year. In the same quarter last year, Quest Diagnostics's revenue was $2.77 billion.
What was DGX's revenue growth in the past year?
As of Q1 2023, Quest Diagnostics's revenue has grown -6.81% year over year. This is 19.82 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 13.01%. Quest Diagnostics's revenue in the past year totalled $10.29 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.